Stock comparison
Curaleaf Holdings, Inc. is 1.4x more valuable than Definium Therapeutics, Inc. by market capitalization ($7.19 B vs $5.21 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
CURLF is larger
Curaleaf Holdings, Inc. is 1.4x more valuable than Definium Therapeutics, Inc. by market capitalization ($7.19 B vs $5.21 B).
Market value leader
CURLF
Curaleaf Holdings, Inc. is 1.4x more valuable than Definium Therapeutics, Inc. by market capitalization ($7.19 B vs $5.21 B).
Profit leader
DFTX
CURLF: -$231.07M vs DFTX: -$183.79M.
| Metric | CURLF | DFTX |
|---|---|---|
| Market cap | $7.19 B | $5.21 B |
| US-listed rank | #1154 | #1389 |
| Revenue (latest FY) | $1.27B | - |
| Net income (latest FY) | -$231.07M | -$183.79M |
| Net margin | -18.2% | - |
| P/E (trailing FY) | - | - |
| SEC filings | 176 | 445 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Curaleaf Holdings, Inc. is 1.4x more valuable than Definium Therapeutics, Inc. by market capitalization ($7.19 B vs $5.21 B).
Full pages: Curaleaf Holdings, Inc. and Definium Therapeutics, Inc., or browse the full rankings.